While still in its infancy, it is estimated that both AR and VR will surpass 100 million users worldwide by 2027. In realising this trend, it is clear that organisations adopting AR/VR app development services to create immersive experiences for their users which may enable them to excel within the realm of healthcare

Ensuring a robust foundation of performance metrics to underpin a strategy is key to navigating the challenges and getting fit for growth. However, amid firefighting to overcome day-to-day challenges, knowing where to start in setting key performance indicators and finding the right ways to track, measure and analyse them to glean actionable insights can often be a minefield that is easily sidelined

In the UK, one in 50 adults is living with a chronic wound, leading to more than £8bn in healthcare costs in 2017/2018. However, these numbers are likely to be higher since the pandemic as a result of reduced care in 2020 and 2021, impacting patient outcomes. With a growing ageing population and the increasing prevalence of people with comorbidities, these costs are likely to continue to rise until new solutions can be implemented to improve current standard care and control

An exploration of the thoughts on the significance of generative AI within life sciences and pharma

What Pharma 4.0 looks like, the strategic role that a laboratory information management system plays and the presentation of a case study that underscores the power of a well-aligned digital strategy to catalyse innovation within organisations

IPT talks to Robert Strzelecki at TenderHut group about the development of AI in the pharma industry and how its implementation will grow the sector

Could the Cloud be the catalyst many pharma QC labs need in their race to the Lab of the Future?

As it grows more sophisticated, artificial intelligence will have transformative implications across virtually every industry on earth. One area in which this impact is already being felt is biotechnology, where it is playing a prominent role in everything from drug and vaccine development to providing global food security

How are digital innovations such as artificial intelligence (AI) and machine learning (ML) helping to improve drug research and development?

Using cloud computing in drug discovery and manufacturing has become increasingly popular over the past few years, however myths around the system still linger. What are these myths, and how can companies overcome them to feel more confident about going digital?

When 450 global pharma leaders were asked about what would make the biggest impact on the success of their digital products and strategies, ‘a shift to a consumer-first mindset’ was the top priority cited (42%). But, what does this really mean, and how can pharma teams achieve it?

What is AI? As it is a relatively new field, we’re now beginning to see particular types show up in the pharma sector, bringing with it huge promises. However, what is ultimately realistic for our industry and for patients?